UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 160

Sortiert nach

A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects

Journal of investigational allergology & clinical immunology, 2023-01, Vol.33 (5), p.362-372

2023

Volltextzugriff (PDF)

High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase

Allergy (Copenhagen), 2022-03, Vol.77 (3), p.883-896

2022

Volltextzugriff (PDF)

Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor

Clinical and experimental allergy, 2012-04, Vol.42 (4), p.590-596

2012

Volltextzugriff (PDF)

An association between Type 2 diabetes and α1-antitrypsin deficiency

Diabetic medicine, 2008-11, Vol.25 (11), p.1370-1373

2008

Volltextzugriff (PDF)

Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents

European journal of pharmaceutical sciences, 2005-04, Vol.24 (5), p.565-573

2005

Volltextzugriff (PDF)

Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.412-420

2013

Volltextzugriff (PDF)

Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis

Scientific reports, 2023-11, Vol.13 (1), p.19649-19649, Article 19649

2023

Volltextzugriff (PDF)

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

Respiratory research, 2016-01, Vol.17 (11), p.10-10, Article 10

2016

Volltextzugriff (PDF)

Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial

Journal of allergy and clinical immunology, 2018-10, Vol.142 (4), p.1338-1341.e9

2018

Volltextzugriff (PDF)

A five-year open follow up of a randomized, double-blind placebo-controlled trial of intralymphatic immunotherapy for birch and grass reveals remaining beneficial effects

Journal of investigational allergology & clinical immunology, 2022-06, p.0

2022

Volltextzugriff (PDF)

Direct nose-to-brain transfer of morphine after nasal administration to rats

Pharmaceutical research, 2006-03, Vol.23 (3), p.565-572

2006

Volltextzugriff (PDF)

The presence of elafin, SLPI, IL1‐RA and STNFα RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation

Mediators of inflammation, 2002, Vol.11 (1), p.7-12

2002

Volltextzugriff (PDF)

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy

Allergy, asthma, and clinical immunology, 2020-04, Vol.16 (1), p.31-31, Article 31

2020

Volltextzugriff (PDF)

The in vitro transport of dihydroergotamine across porcine nasal respiratory and olfactory mucosa and the effect of a novel powder formulation

Journal of drug delivery science and technology, 2007, Vol.17 (4), p.267-271

2007

Volltextzugriff (PDF)

Novel strategies for the treatment of grass pollen-induced allergic rhinitis

Expert opinion on biological therapy, 2016-09, Vol.16 (9), p.1143-1150

2016

Volltextzugriff (PDF)

HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study

Allergy, asthma, and clinical immunology, 2021-06, Vol.17 (1), p.1-55, Article 55

2021

Volltextzugriff (PDF)

The effect of immediate‐hypersensitivity reactions on the level of SLPI, granulocyte elastase, α1‐antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge

Allergy (Copenhagen), 1999, Vol.54 (8), p.857-864

1999

Volltextzugriff (PDF)

Identification of SLPI (Secretory Leukocyte Protease Inhibitor) in Human Mast Cells Using Immunohistochemistry and In Situ Hybridisation

Biological chemistry, 1999-04, Vol.380 (4), p.489-493

1999

Volltextzugriff (PDF)

Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release

Respiratory research, 2005, Vol.6 (1)

2005

Volltextzugriff (PDF)

Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR 2 inhibitor

Clinical and experimental allergy, 2012-04, Vol.42 (4), p.590-596

2012

Volltextzugriff (PDF)

Allergen-specific immunotherapy increases plasma gelsolin levels

American journal of rhinology & allergy, 2014-05, Vol.28 (3), p.e136-e140

2014

Volltextzugriff (PDF)

IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release

Mediators of Inflammation, 1998-01, Vol.1998 (3), p.217-220

1998

Volltextzugriff (PDF)

Increased Plasma Levels of Serine Proteinase Inhibitors in Lung Cancer Patients

Anticancer research, 2004-01, Vol.24 (1), p.241-247

2004

Volltextzugriff (PDF)

An association between Type 2 diabetes and α 1 ‐antitrypsin deficiency

Diabetic medicine, 2008-11, Vol.25 (11), p.1370-1373

2008

Volltextzugriff (PDF)

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa

Mediators of Inflammation, 2001, Vol.2001 (5), p.269-272

2001

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects

High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase

Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor

An association between Type 2 diabetes and α1-antitrypsin deficiency

Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents

Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis

Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial

A five-year open follow up of a randomized, double-blind placebo-controlled trial of intralymphatic immunotherapy for birch and grass reveals remaining beneficial effects

Direct nose-to-brain transfer of morphine after nasal administration to rats

The presence of elafin, SLPI, IL1‐RA and STNFα RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy

The in vitro transport of dihydroergotamine across porcine nasal respiratory and olfactory mucosa and the effect of a novel powder formulation

Novel strategies for the treatment of grass pollen-induced allergic rhinitis

HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study

The effect of immediate‐hypersensitivity reactions on the level of SLPI, granulocyte elastase, α1‐antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge

Identification of SLPI (Secretory Leukocyte Protease Inhibitor) in Human Mast Cells Using Immunohistochemistry and In Situ Hybridisation

Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release

Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR 2 inhibitor

Allergen-specific immunotherapy increases plasma gelsolin levels

IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release

Increased Plasma Levels of Serine Proteinase Inhibitors in Lung Cancer Patients

An association between Type 2 diabetes and α 1 ‐antitrypsin deficiency

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa

Suchergebnisse filtern